Small Molecules

21 Mar 2007 Dharma Therapeutic Shows IDDS is Effective in Reducing Pain Associated with Insertion of an Intravenous Catheter in their Phase 2 Clinical Trial
21 Mar 2007 Resverlogix Advances RVX-208 IND Program to Parallel Human Microdosing
21 Mar 2007 Cannasat Therapeutics and IntelGenx Enter Into Agreement to Develop Cannabinoid-Based Products for the Treatment of Mood Disorders Such as Anxiety and Depression
21 Mar 2007 Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
21 Mar 2007 Takeda Submits a European Marketing Authorization
21 Mar 2007 Astellas Receives an FDA Action Letter for Prograf sNDA
21 Mar 2007 Jerini Announces Establishment of Wholly-Owned US Subsidiary Aimed at Developing Treatments for Eye Diseases
21 Mar 2007 Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
21 Mar 2007 Cell Therapeutics Inc. (CTI) Files for Special Protocol Assessment (SPA) for XYOTAX(TM) PGT307 Lung Cancer Trial in Women
21 Mar 2007 Avexa Limited (AVX.AX) Reports Positive Phase IIb Results
21 Mar 2007 Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
21 Mar 2007 Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
20 Mar 2007 Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet Primary Endpoint
20 Mar 2007 ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
20 Mar 2007 Neuropharma presents advances in the development of NP-61 at the Alzheimer's and Parkinson's Diseases International Conference
20 Mar 2007 Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
20 Mar 2007 Akesis Pharmaceuticals Obtains Exclusive License for Proprietary Clinical Stage Diabetes Therapy from the University of British Columbia
20 Mar 2007 New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
20 Mar 2007 In new study, Duloxetine reduced non-specific pain and emotional symptoms associated with depression
20 Mar 2007 Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
20 Mar 2007 Corcept Therapeutics Inc. Announces Phase 3 Study Evaluating CORLUX(R) for Psychotic Major Depression Misses Primary Endpoint
20 Mar 2007 Advanced Magnetics Completes Enrollment in Final Planned Phase III Study of Ferumoxytol as an IV Iron Replacement Therapeutic
19 Mar 2007 SEROQUEL(R) Sustained Release Schizophrenia Data presented at ECP Congress in Madrid
17 Mar 2007 Abeille Licenses AB-1001 to SymBio Pharmaceuticals for Commercialization in Japan and Pacific Rim Countries
17 Mar 2007 Amicus Therapeutics, Inc. Completes Phase 2 Enrollment of Amigal(TM) for Fabry Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up